Human rDNA copy number is unstable in metastatic breast cancers

被引:32
|
作者
Valori, Virginia [1 ]
Tus, Katalin [2 ,8 ,9 ]
Laukaitis, Christina [3 ,4 ]
Harris, David T. [5 ,6 ]
LeBeau, Lauren [2 ]
Maggert, Keith A. [4 ,7 ]
机构
[1] Univ Arizona, Coll Med, Dept Appl Biosci, Tucson, AZ 85724 USA
[2] Univ Arizona, Coll Med, Dept Pathol, Tucson, AZ 85724 USA
[3] Univ Arizona, Coll Med, Dept Med, Tucson, AZ 85724 USA
[4] Univ Arizona, Coll Med, Ctr Canc, Tucson, AZ 85724 USA
[5] Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85724 USA
[6] Univ Arizona, Coll Med, Arizona Hlth Sci Ctr Biorepository, Tucson, AZ 85724 USA
[7] Univ Arizona, Coll Med, Dept Cellular & Mol Med, Tucson, AZ 85724 USA
[8] Spartanburg Med Ctr, Carolinas Pathol Grp, Spartanburg, SC USA
[9] Spartanburg Reg Healthcare Syst, Spartanburg, SC USA
关键词
Ribosomal DNA (rDNA); invasive breast carcinoma; heterochromatin; repeat; qPCR; copy number polymorphism; RIBOSOMAL-RNA GENES; GENOME INSTABILITY; IN-SITU; TELOMERASE ACTIVITY; HETEROCHROMATIN PROTEIN-1; EPIGENETIC REGULATION; DNA; EXPRESSION; CARCINOMA; VARIANTS;
D O I
10.1080/15592294.2019.1649930
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chromatin-mediated silencing, including the formation of heterochromatin, silent chromosome territories, and repressed gene promoters, acts to stabilize patterns of gene regulation and the physical structure of the genome. Reduction of chromatin-mediated silencing can result in genome rearrangements, particularly at intrinsically unstable regions of the genome such as transposons, satellite repeats, and repetitive gene clusters including the rRNA gene clusters (rDNA). It is thus expected that mutational or environmental conditions that compromise heterochromatin function might cause genome instability, and diseases associated with decreased epigenetic stability might exhibit genome changes as part of their aetiology. We find the support of this hypothesis in invasive ductal breast carcinoma, in which reduced epigenetic silencing has been previously described, by using a facile method to quantify rDNA copy number in biopsied breast tumours and pair-matched healthy tissue. We found that rDNA and satellite DNA sequences had significant copy number variation - both losses and gains of copies - compared to healthy tissue, arguing that these genome rearrangements are common in developing breast cancer. Thus, any proposed aetiology onset or progression of breast cancer should consider alterations to the epigenome, but must also accommodate concomitant changes to genome sequence at heterochromatic loci.
引用
收藏
页码:85 / 106
页数:22
相关论文
共 50 条
  • [41] Classification of cancers based on copy number variation landscapes
    Zhang, Ning
    Wang, Meng
    Zhang, Peiwei
    Huang, Tao
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2016, 1860 (11): : 2750 - 2755
  • [42] Copy number alteration of neuropeptides and receptors in multiple cancers
    Min Zhao
    Tianfang Wang
    Qi Liu
    Scott Cummins
    Scientific Reports, 7
  • [43] RNA polymerase II-mediated rDNA transcription mediates rDNA copy number expansion in Drosophila
    Watase, George J.
    Yamashita, Yukiko M.
    PLOS GENETICS, 2024, 20 (05):
  • [44] Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations
    David Brown
    Dominiek Smeets
    Borbála Székely
    Denis Larsimont
    A. Marcell Szász
    Pierre-Yves Adnet
    Françoise Rothé
    Ghizlane Rouas
    Zsófia I. Nagy
    Zsófia Faragó
    Anna-Mária Tőkés
    Magdolna Dank
    Gyöngyvér Szentmártoni
    Nóra Udvarhelyi
    Gabriele Zoppoli
    Lajos Pusztai
    Martine Piccart
    Janina Kulka
    Diether Lambrechts
    Christos Sotiriou
    Christine Desmedt
    Nature Communications, 8
  • [45] Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations
    Brown, David
    Smeets, Dominiek
    Szekely, Borbala
    Larsimont, Denis
    Szasz, A. Marcell
    Adnet, Pierre-Yves
    Rothe, Francoise
    Rouas, Ghizlane
    Nagy, Zsofia, I
    Farago, Zsofia
    Tokes, Anna-Maria
    Dank, Magdolna
    Szentmartoni, Gyongyver
    Udvarhelyi, Nora
    Zoppoli, Gabriele
    Pusztai, Lajos
    Piccart, Martine
    Kulka, Janina
    Lambrechts, Diether
    Sotiriou, Christos
    Desmedt, Christine
    NATURE COMMUNICATIONS, 2017, 8
  • [46] Assessment of HER2 status in invasive breast cancers with increased centromere 17 copy number
    Jang, Min Hye
    Kim, Eun Joo
    Kim, Hyun Jeong
    Chung, Yul Ri
    Park, So Yeon
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 153 (01) : 67 - 77
  • [47] Assessment of HER2 status in invasive breast cancers with increased centromere 17 copy number
    Min Hye Jang
    Eun Joo Kim
    Hyun Jeong Kim
    Yul Ri Chung
    So Yeon Park
    Breast Cancer Research and Treatment, 2015, 153 : 67 - 77
  • [48] Evaluation of Next Generation Sequencing for Detecting HER2 Copy Number in Breast and Gastric Cancers
    Niu, Dongfeng
    Li, Lei
    Yu, Yang
    Zang, Wanchun
    Li, Zhongwu
    Zhou, Lixin
    Jia, Ling
    Rao, Guanhua
    Gao, Lianju
    Cheng, Gang
    Ji, Ke
    Lin, Dongmei
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (04) : 2577 - 2585
  • [49] Comprehensive characterization and clinical relevance of the SWI/SNF copy number aberrations across human cancers
    Xing, Zhiwei
    Ma, Buhuan
    Sun, Weiting
    Sun, Yimin
    Liu, Caixia
    HEREDITAS, 2021, 158 (01)
  • [50] Characterization and clinical relevance of PDGFRA pathway copy number variation gains across human cancers
    Lizhu Liu
    Lihong Wu
    Dan Shan
    Bo Han
    Molecular Genetics and Genomics, 2022, 297 : 561 - 571